355 related articles for article (PubMed ID: 2329823)
1. Rabbit antithymocyte globulin. A 10-year experience in cardiac transplantation.
Copeland JG; Icenogle TB; Williams RJ; Rosado LJ; Butman SM; Vasu MA; Sethi GK; McDonald AN; Klees E; Rhenman MJ
J Thorac Cardiovasc Surg; 1990 May; 99(5):852-60. PubMed ID: 2329823
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3.
Kirklin JK; Bourge RC; White-Williams C; Naftel DC; Thomas FT; Thomas JM; Phillips MG
J Thorac Cardiovasc Surg; 1990 Apr; 99(4):716-24. PubMed ID: 2108282
[TBL] [Abstract][Full Text] [Related]
3. Pediatric cardiac transplantation. The Stanford experience.
Sarris GE; Smith JA; Bernstein D; Griffin ML; Pitlick PT; Baum D; Billingham ME; Oyer PE; Stinson EB; Starnes VA
Circulation; 1994 Nov; 90(5 Pt 2):II51-5. PubMed ID: 7955282
[TBL] [Abstract][Full Text] [Related]
4. Heart transplantation in females.
Esmore D; Keogh A; Spratt P; Jones B; Chang V
J Heart Lung Transplant; 1991; 10(3):335-41. PubMed ID: 1854761
[TBL] [Abstract][Full Text] [Related]
5. Induction of immunosuppression with rabbit antithymocyte globulin: five-year experience in cardiac transplantation.
Carrier M; Pelletier GB; Cartier R; Leclerc Y; Robitaille D; Pelletier LC
Can J Cardiol; 1993 Mar; 9(2):171-6. PubMed ID: 8490788
[TBL] [Abstract][Full Text] [Related]
6. Rabbit antithymocyte globulin as induction immunotherapy for pediatric deceased donor kidney transplantation.
Kamel MH; Mohan P; Little DM; Awan A; Hickey DP
J Urol; 2005 Aug; 174(2):703-7. PubMed ID: 16006954
[TBL] [Abstract][Full Text] [Related]
7. Comparative trial of immunoprophylaxis with RATG versus OKT3.
Griffith BP; Kormos RL; Armitage JM; Dummer JS; Hardesty RL
J Heart Transplant; 1990; 9(3 Pt 2):301-5. PubMed ID: 2113093
[TBL] [Abstract][Full Text] [Related]
8. OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients.
Prieto M; Lake KD; Pritzker MR; Jorgensen CR; Arom KV; Love KR; Emery RW
J Heart Lung Transplant; 1991; 10(6):901-11. PubMed ID: 1661608
[TBL] [Abstract][Full Text] [Related]
9. Midterm results of a prospective randomized comparison of two different rabbit-antithymocyte globulin induction therapies after heart transplantation.
De Santo LS; Della Corte A; Romano G; Amarelli C; Onorati F; Torella M; De Feo M; Marra C; Maiello C; Giannolo B; Casillo R; Ragone E; Grimaldi M; Utili R; Cotrufo M
Transplant Proc; 2004 Apr; 36(3):631-7. PubMed ID: 15110616
[TBL] [Abstract][Full Text] [Related]
10. Unique antithymocyte serum versus OKT3 for induction immunotherapy after heart transplantation.
Frist WH; Merrill WH; Eastburn TE; Atkinson JB; Stewart JR; Hammon JW; Bender JW
J Heart Transplant; 1990; 9(5):489-94. PubMed ID: 2121921
[TBL] [Abstract][Full Text] [Related]
11. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
Koch A; Daniel V; Dengler TJ; Schnabel PA; Hagl S; Sack FU
J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731
[TBL] [Abstract][Full Text] [Related]
12. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
Schulz T; Kapischke M; Busing M
Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
[TBL] [Abstract][Full Text] [Related]
13. Impacts of low-dose steroids and prophylactic monoclonal versus polyclonal antibodies on acute rejection in cyclosporine- and azathioprine-immunosuppressed cardiac allografts.
Laufer G; Laczkovics A; Wollenek G; Schreiner W; Sochor H; Holzinger C; Buchelt M; Fasol R; Wolner E
J Heart Transplant; 1989; 8(3):253-61. PubMed ID: 2661776
[TBL] [Abstract][Full Text] [Related]
14. Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial.
Eason JD; Loss GE; Blazek J; Nair S; Mason AL
Liver Transpl; 2001 Aug; 7(8):693-7. PubMed ID: 11510013
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts.
Soulillou JP; Cantarovich D; Le Mauff B; Giral M; Robillard N; Hourmant M; Hirn M; Jacques Y
N Engl J Med; 1990 Apr; 322(17):1175-82. PubMed ID: 2157982
[TBL] [Abstract][Full Text] [Related]
16. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
Guttmann RD; Flemming C
Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
[TBL] [Abstract][Full Text] [Related]
18. Rabbit antithymocyte globulin as induction immunotherapy in pediatric heart transplantation.
Di Filippo S; Boissonnat P; Sassolas F; Robin J; Ninet J; Champsaur G; Bozio A
Transplantation; 2003 Feb; 75(3):354-8. PubMed ID: 12589158
[TBL] [Abstract][Full Text] [Related]
19. Independent risk factors predicting acute graft rejection in cardiac transplant recipients treated by triple drug immunosuppression.
Laufer G; Miholic J; Laczkovics A; Wollenek G; Holzinger C; Hajek-Rosenmeier A; Wuzl G; Schreiner W; Buxbaum P; Wolner E
J Thorac Cardiovasc Surg; 1989 Dec; 98(6):1113-21. PubMed ID: 2586129
[TBL] [Abstract][Full Text] [Related]
20. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation.
Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G
J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
